A new model has projected a substantial rise in the burden of metabolic dysfunction-associated steatotic liver disease in the ...

Yale professors of medicine worked with a group of researchers and physicians to create 20 recommendations for the ...

LONDON - RTW Biotech Opportunities Ltd (LSE: RTW), a London Stock Exchange-listed investment company, announced that its ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at high risk for hepatitis B reactivation. (Gastroenterology) Researchers ...

An estimated 25 percent of adults in the United States have MASLD. Of those, 20 percent have MASH. Obesity is one of the leading causes of MASLD and MASH. About 75 percent of people with ...

National estimates of prevalence for the US population are lacking. Objective: To examine the public health problem posed by eczema, AD, and eczematous conditions in the United States by analyzing ...

Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...